Literature DB >> 9245925

Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

H Miyaji1, S Ito, T Azuma, Y Ito, Y Yamazaki, Y Ohtaki, F Sato, M Hirai, M Kuriyama, Y Kohli.   

Abstract

BACKGROUND AND AIMS: Helicobacter pylori has strong urease activity. Ammonia produced by H pylori in the stomach can be a source of systemic ammonia in patients with hepatic dysfunction. The effect of the eradication of H pylori on hyperammonaemia was examined in patients with liver cirrhosis. SUBJECTS AND METHODS: Ammonia concentrations in blood and gastric juice were analysed in 50 patients with liver cirrhosis and hyperammonaemia. All patients were first treated with a low protein diet, kanamycin, lactulose, and branched chain enriched amino acid solution. Hyperammonaemia remained in 18 patients. These 18 patients were divided into three groups according to the status of H pylori infection; those with a diffuse distribution of H pylori in the stomach (group I), those with a regional distribution (group II), and those without H pylori (group III). These patients were given 30 mg iansoprazole, 1000 mg amoxicillin, and 400 mg clarithromycin or 500 mg metronidazole for two weeks to eradicate H pylori.
RESULTS: In group I ammonia concentrations in blood and gastric juice were significantly reduced after H pylori eradication. The blood ammonia concentration at 12 weeks after the eradication was still significantly lower than that before eradication. In groups II and III the ammonia concentrations in blood and gastric juice were not significantly reduced after eradication therapy.
CONCLUSIONS: The diffuse distribution of H-pylori in the stomach contributes partly to hyperammonaemia in patients with liver cirrhosis, and the eradication of H pylori is effective in patients with hyperammonaemia with diffuse H pylori infection in the stomach.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245925      PMCID: PMC1027196          DOI: 10.1136/gut.40.6.726

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?

Authors:  L Capocaccia; O Riggio
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

Review 2.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

3.  Purification and characterization of urease from Helicobacter pylori.

Authors:  B E Dunn; G P Campbell; G I Perez-Perez; M J Blaser
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

4.  Gastric adenocarcinoma and Helicobacter pylori infection.

Authors:  N J Talley; A R Zinsmeister; A Weaver; E P DiMagno; H A Carpenter; G I Perez-Perez; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1991-12-04       Impact factor: 13.506

5.  Effect of three antibacterial drugs in lowering blood & stool ammonia production in hepatic encephalopathy.

Authors:  T Alexander; K Thomas; A M Cherian
Journal:  Indian J Med Res       Date:  1992-10       Impact factor: 2.375

6.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

7.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

8.  Effects of cations on Helicobacter pylori urease activity, release, and stability.

Authors:  G I Pérez-Pérez; C B Gower; M J Blaser
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

9.  The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion.

Authors:  P B Mortensen
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

10.  Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach.

Authors:  M J Blaser; K Kobayashi; T L Cover; P Cao; I D Feurer; G I Pérez-Pérez
Journal:  Int J Cancer       Date:  1993-11-11       Impact factor: 7.396

View more
  12 in total

Review 1.  Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.

Authors:  G Realdi; M P Dore; L Fastame
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

2.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

3.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 4.  Extradigestive manifestations of Helicobacter pylori gastric infection.

Authors:  A Gasbarrini; F Franceschi; A Armuzzi; V Ojetti; M Candelli; E S Torre; A De Lorenzo; M Anti; S Pretolani; G Gasbarrini
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

5.  Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis.

Authors:  H Suto; T Azuma; S Ito; M Ohtani; M Dojo; Y Ito; Y Kohli; M Kuriyama
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

6.  Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication.

Authors:  Avinash Agrawal; Alok Gupta; Mam Chandra; Sciddhartha Koowar
Journal:  Indian J Gastroenterol       Date:  2011-03-18

7.  Breath ammonia measurement in Helicobacter pylori infection.

Authors:  David J Kearney; Todd Hubbard; David Putnam
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

8.  Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.

Authors:  Shu-Jie Chen; Liang-Jing Wang; Qin Zhu; Jian-Ting Cai; Tao Chen; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

9.  Role of Helicobacter pylori and hyperammonemia in subclinical hepatic encephalopathy in cirrhosis of liver.

Authors:  C Rekha; Srinivasa Phanidhar; A Vidya Sagar; A Revathi; W A Asra
Journal:  Indian J Clin Biochem       Date:  2007-09

Review 10.  Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.